This company is severely at the leverage of market conditions, and each passing month dwindles chances of a strong restoration. Consensus is Weis went dark to save on SEC costs while biotech (and the general market) decides which direction it's heading.
I have a hefty amount of shares in this, but I'm by no means blinded by the reality of the situation. If we get financing, the market has showed strong support in the past to $1 PPS. As I've said, don't break the bank.
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM